SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is experiencing a strong rally ahead of its quarterly delivery report, driven by optimistic market expectations that it will significantly outperform analyst estimates. Community sentiment is deeply divided, with bulls pointing to delivery momentum and potential AI catalysts, while bears remain focused on valuation concerns and skepticism surrounding the sustainability of the stock's recent gains.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is seeing active community debate as investors react to strong delivery guidance and reports of successful production ramps for the R2 model. Traders are closely watching key technical resistance levels while debating whether the current momentum represents a long-term fundamental breakout or a short-term volatility play.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as retail investors ramp up speculation around upcoming global expansion announcements and potential catalysts in the Middle East, while simultaneously monitoring a high concentration of short interest that community members believe is nearing a squeeze point. Discussions are heavily focused on the clinical potential of NK cell therapies and the anticipation of stronger commercial traction following recent executive travel and manufacturing updates.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull is trending as investors debate its long-term growth potential and platform expansion compared to larger brokerage peers, while a vocal community segment focuses on technical support levels and recent institutional accumulation. Sentiment remains deeply divided, with some traders optimistic about a potential breakout driven by platform scaling, while others express frustration over persistent price stagnation and perceived market manipulation.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is experiencing intense market volatility driven by broader semiconductor sector rebalancing and concerns over AI-related compute demand. Despite the price swings, the community remains deeply divided between those viewing the recent dip as a strategic entry point and others anticipating further downside following a period of rapid growth.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce Holding PLC (ADR)

Rolls-Royce is trending as the community highlights a major nuclear energy win with Sweden selecting the company's Small Modular Reactors, fueling long-term optimism alongside expectations for upcoming defense contract announcements. Investors are actively discussing the stock's resilient upward momentum and potential for significant growth as a key player in the evolving global aerospace and nuclear infrastructure sectors.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is generating significant community conversation following a leadership shakeup, including the departure of its COO and a series of workforce reductions aimed at cutting costs. Traders are closely monitoring these organizational changes alongside speculation about future robotaxi partnerships and potential short-squeeze activity driven by high borrow fees.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

SPY is trending as investors react to a cooling labor market, with the June payroll growth falling short of consensus estimates and fueling speculation that the Federal Reserve may soon pivot toward rate cuts. The community remains deeply divided, with some traders optimistic that weaker economic data serves as a 'Goldilocks' catalyst for further gains, while others express frustration over market volatility, perceived data manipulation, and the potential for a broader bubble in AI-linked sectors.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster is trending as investors capitalize on the company's expanding role in the physical AI and robotics sectors, bolstered by a significant public stock offering to fund growth and recent strategic successes like its BABA Act certification. The community is actively debating the balance between short-term dilution from the offering and the long-term potential for Ouster to become a foundational sensing layer in automated heavy machinery and smart infrastructure.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is experiencing significant market volatility driven by institutional accumulation and heavy short interest, with investors closely watching the company's expansion into AI-enabled diagnostic platforms and upcoming investor day. The community is actively debating the stock's long-term potential as a healthcare data infrastructure play against immediate concerns over stock price performance and ongoing short-selling pressure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ADCT this is going to x5 before EOY

https://ir.adctherapeutics.com/2026-06-30-ADC-Therapeutics-Announces-Completion-of-Enrollment-in-LOTIS-7-Phase-1b-ZYNLONTA-R-Combination-Trial

C.A.M

Blake

RICHHOMIΞQUARK

alik

100 r/r DLBCL patients treated at the selected 150 µg/kg dose of ZYNLONTA® plus glofitamab Full data expected in fourth quarter of 2026 LAUSANNE, Switzerland, June 30, 2026 /PRNewswire/ -- ADC...

Investors | ADC Therapeutics

ADC Therapeutics Announces Completion of Enrollment in LOTIS-7 Phase 1b ZYNLONTA® Combination Trial

StockTwits For Android 

Adc Therapeutics SA

Spartrap

StockTwits for iOS

@Spartrap I am hoping it 5x from $4 - pre LOTIS-5 overreaction

StockTwits Web

 I am hoping it 5x from $4 - pre LOTIS-5 overreaction

@Spartrap that would be a great Christmas present LOL

 that would be a great Christmas present LOL